Aligos Therapeutics, Inc. (ALGS) vs Lite Strategy, Inc. (LITS)
- Aligos Therapeutics, Inc. ALGS 4.09 −9.31%
- Lite Strategy, Inc. LITS 1.01 +4.12%
Aligos Therapeutics, Inc. and Lite Strategy, Inc. are both Biotechnology companies. Aligos Therapeutics, Inc. and Lite Strategy, Inc. are of similar size ($29.6M and $28.2M). Aligos Therapeutics, Inc. grew revenue faster over the last twelve months: 1,171.6% against 152.9%. Lite Strategy, Inc. has the higher net margin (0.00% vs −197.0%) and the higher return on invested capital (−115.9% vs −400.9%). Across the 16 metrics below, Lite Strategy, Inc. leads on 9 and Aligos Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | ALGS | LITS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 68.51% |
| Operating margin | (215.55%) | 0.00% | 0.00% |
| Net margin | (197.01%) | 0.00% | 0.00% |
| Free cash flow margin | (203.21%) | 0.00% | 0.00% |
| Return on equity | (159.46%) | (243.02%) | (51.96%) |
| Return on assets | (84.46%) | (233.37%) | (46.06%) |
| Return on invested capital | (400.91%) | (115.85%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack